Milestone Pharmaceuticals Inc. — Director's Dealing 2020

Jan 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2020-01-23

Reporting Person: Hasija Amit (CFO & EVP of Corp. Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-23	Employee Stock Option (right to buy)	$21.48	A	82000	Acquired	2030-01-23	Common Shares (82000)	Direct

Footnotes

F1: One-fourth (1/4th) of the shares subject to the option vest on January 23, 2021 and one forty-eighth (1/48th) of the shares subject to the option vest on each one month anniversary thereafter, subject to the Reporting Person continuing to provide service through each such date.